DEUTSCHE BANK AG\ - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 327 filers reported holding GW PHARMACEUTICALS PLC in Q2 2019. The put-call ratio across all filers is 1.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$80,000
-99.8%
369
-99.9%
0.00%
-100.0%
Q4 2020$37,659,000
+25.5%
326,307
+5.9%
0.02%
+9.5%
Q3 2020$29,998,000
-20.7%
308,143
+0.0%
0.02%
-27.6%
Q2 2020$37,815,000
+56.1%
308,141
+11.4%
0.03%
+31.8%
Q1 2020$24,228,000
-23.2%
276,678
-8.3%
0.02%
+4.8%
Q4 2019$31,558,000
-22.0%
301,839
-14.2%
0.02%
-25.0%
Q3 2019$40,445,000
-19.2%
351,615
+21.1%
0.03%
-3.4%
Q2 2019$50,051,000
+16.4%
290,342
+13.9%
0.03%
+11.5%
Q1 2019$42,983,000
+63.1%
255,003
-5.8%
0.03%
+36.8%
Q4 2018$26,350,000
-67.0%
270,575
-41.4%
0.02%
-17.4%
Q3 2018$79,769,000
-14.5%
461,788
-30.9%
0.02%
-14.8%
Q2 2018$93,253,000
+206.5%
668,299
+147.5%
0.03%
+80.0%
Q1 2018$30,426,000
+1.0%
270,057
+18.3%
0.02%
-21.1%
Q4 2017$30,124,000
+333.9%
228,206
+233.5%
0.02%
+280.0%
Q3 2017$6,942,000
-53.2%
68,423
-53.8%
0.01%
-54.5%
Q2 2017$14,848,000
-35.0%
148,133
-21.6%
0.01%
-35.3%
Q1 2017$22,835,000
+15.8%
188,829
+7.0%
0.02%
+6.2%
Q4 2016$19,725,000
+42.6%
176,527
+69.4%
0.02%
+60.0%
Q3 2016$13,828,000
+78.7%
104,194
+23.3%
0.01%
+100.0%
Q2 2016$7,736,000
+153.2%
84,499
+99.5%
0.01%
+150.0%
Q1 2016$3,055,000
-44.3%
42,364
-46.3%
0.00%
-50.0%
Q4 2015$5,482,000
+774.3%
78,961
+1048.9%
0.00%
Q3 2015$627,000
+6.5%
6,873
+43.1%
0.00%
Q2 2015$589,000
-2.2%
4,804
-27.5%
0.00%
Q1 2015$602,000
+225.4%
6,623
+141.2%
0.00%
Q4 2014$185,000
+131.2%
2,746
+174.6%
0.00%
Q3 2014$80,000
-31.0%
1,000
-8.4%
0.00%
Q2 2014$116,000
-87.5%
1,092
-93.0%
0.00%
-100.0%
Q1 2014$931,00015,7000.00%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q2 2019
NameSharesValueWeighting ↓
Chicago Capital Management, LLC 86,069$18,668,0008.69%
BARDIN HILL MANAGEMENT PARTNERS LP 170,108$36,897,0006.84%
HARVEST MANAGEMENT LLC 44,100$9,565,0005.72%
Twin Securities, Inc. 39,541$8,576,0005.50%
TIG Advisors, LLC 572,743$124,228,0004.67%
ALPINE ASSOCIATES MANAGEMENT INC. 787,500$170,810,0004.63%
First Trust Capital Management L.P. 105,822$22,953,0004.49%
Pentwater Capital Management LP 2,102,104$455,946,0004.35%
OMNI PARTNERS LLP 403,061$87,424,0004.31%
SPRING CREEK CAPITAL LLC 370,000$80,253,0003.47%
View complete list of GW PHARMACEUTICALS PLC shareholders